Homologous COVID-19 BNT162b2 mRNA Vaccination at a German Tertiary Care University Hospital: A Survey-Based Analysis of Reactogenicity, Safety, and Inability to Work among Healthcare Workers

Homologous COVID-19 BNT162b2 mRNA Vaccination at a German Tertiary Care University Hospital: A Survey-Based Analysis of Reactogenicity, Safety, and Inability to Work among Healthcare Workers

At the start of the SARS-CoV-2 pandemic, healthcare workers had an increased risk of acquiring coronavirus disease (COVID)-19. As tertiary care hospitals are critical for the treatment of severely ill patients, the University Hospital Erlangen offered BNT162b2 mRNA vaccination against COVID-19 to al...

Full description

Bibliographic Details
Main Authors: Valentin Niekrens, Jan Esse, Jürgen Held, Carina Sophia Knobloch, Philipp Steininger, Bernd Kunz, Christof Seggewies, Christian Bogdan
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
mRNA vaccination
BNT162b2
Comirnaty<sup>®</sup>
reactogenicity
Online Access:https://www.mdpi.com/2076-393X/10/5/650

Internet

https://www.mdpi.com/2076-393X/10/5/650

Similar Items